OS Therapies (OSTX)
NYSE: OSTX
· Real-Time Price · USD
2.26
-0.24 (-9.60%)
At close: Aug 28, 2025, 3:59 PM
2.24
-0.88%
After-hours: Aug 28, 2025, 07:59 PM EDT
OS Therapies Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Mar 31, 2022 | Dec 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 114.6K | 2.78K | 2.78K | 1.39K | 4.71K | 4.01K | 3.31K | 3.31K | 1.21 | 19.69 | 19.69 | 19.69 | 18.48 |
Gross Profit | -114.6K | -2.78K | -2.78K | -1.39K | -4.71K | -4.01K | -3.31K | -3.31K | -1.21 | -19.69 | -19.69 | -19.69 | -18.48 |
Operating Income | -5.01B | -5.01B | -6.81M | -5M | -3.19M | -2.41M | -1.78M | -626.51K | -5.19K | -4.94K | -3.9K | -2.16K | -1.27K |
Interest Income | 130.00 | 66.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -14.28M | -11.3M | -8.88M | -7.36M | -6.46M | -4.9M | -3.44M | -1.98M | -8.27K | -8.12K | -6.28K | -3.72K | -2.36K |
Net Income | -3.89B | -3.88B | -8.88M | -7.36M | -6.46M | -4.9M | -3.44M | -1.98M | -8.27K | -8.12K | -6.28K | -3.72K | -2.36K |
Selling & General & Admin | 3.7B | 3.69B | 3.97M | 2.01M | 952.24K | 569.53K | 301.4K | 169.16K | 1.66K | 1.7K | 1.4K | 758.69 | 555.27 |
Research & Development | 1.31B | 1.31B | 2.84M | 2.99M | 2.23M | 1.84M | 1.48M | 457.35K | 3.53K | 3.23K | 2.48K | 1.38K | 692.97 |
Other Expenses | -4.99B | -4.99B | -1.39K | 5.15K | 5.15K | 5.15K | 5.15K | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Operating Expenses | 15.13M | 11.18M | 6.81M | 5M | 3.19M | 2.41M | 1.78M | 626.51K | 5.19K | 4.92K | 3.88K | 2.14K | 1.25K |
Interest Expense | 445.39K | 1.22M | 2.05M | 2.35M | 3.27M | 2.49M | 1.66M | 1.35M | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.31M | 5.25M | 881K | 5M | 3.19M | 2.41M | 1.78M | 626.51K | 5.19K | 4.94K | 3.9K | 2.16K | 1.27K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 25.11M | 21.25M | 123.77M | 15.9M | 20.6M | 20.05M | 20.05M | 20.05M | 5.27M | 10.04M | 9.86M | 9.76M | 13.41M |
Shares Outstanding (Diluted) | 25.11M | 21.25M | 123.77M | 15.9M | 20.6M | 20.05M | 20.05M | 23.1M | 5.34M | 10.21M | 9.98M | 9.98M | 13.41M |
EPS (Basic) | -0.58 | -0.48 | -0.37 | -0.4 | -0.32 | -0.25 | -0.18 | -0.1 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
EPS (Diluted) | -0.58 | -0.48 | -0.37 | -0.4 | -0.32 | -0.25 | -0.18 | -0.1 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
EBITDA | -5.01B | -5.01B | -6.83M | -5M | -3.18M | -2.41M | -1.78M | -623.19K | -5.19K | -4.94K | -3.9K | -2.16K | -1.27K |
EBIT | -13.83M | -10.08M | -6.83M | -5M | -3.19M | -2.41M | -1.78M | -626.51K | -5.19K | -4.94K | -3.9K | -2.16K | -1.27K |
Depreciation & Amortization | 111.82K | n/a | n/a | 1.39K | 4.71K | 4.01K | 3.32K | 3.32K | 1.31 | 0.70 | 0.60 | 0.40 | 0.20 |